Identifying Optimal Treatment Strategies for Tuberculosis Treatment |
Rada Savic, PhD |
Kenya, Malawi, Uganda, Zimbabwe, South Africa, China, India, Viet Nam, Thailand, Brazil, Peru, Haiti |
|
|
University of California Global Health Institute Program for Fellows and Scholars |
Craig Cohen, MD, MPH |
Kenya, Malawi, Tanzania, Zimbabwe, Congo (Kinshasa), Botswana, South Africa, Ghana, Bangladesh, India, Peru |
|
|
Mentoring Multidisciplinary Patient-Oriented Research in Engagement in HIV Care |
|
Kenya, Uganda, Zambia, Zimbabwe |
|
|
Enabling Better Planned Transitions of Malaria Programming from Global Fund Financing to Domestic Financing |
Sara Fewer |
Eritrea, Ethiopia, Kenya, Malawi, Mozambique, Rwanda, Somalia, South Sudan, Uganda, Tanzania, Zambia, Zimbabwe, Cameroon, Central African Republic, Chad, Congo (Kinshasa), Congo (Brazzaville), Equatorial Guinea, Benin, Burkina Faso, Ivory Coast, Gambia, Ghana, Guinea, Guinea-Bissau, Liberia, Mali, Niger, Afghanistan, Bangladesh, India, Nepal, Brunei, Cambodia, Myanmar, Honduras, Cuba, Haiti |
|
|
Implementation of The Global Fund's Programmatic Quality Assurance and Improvement Approach |
George Rutherford, MD |
Burundi, Eritrea, Ethiopia, Kenya, Madagascar, Malawi, Mozambique, Rwanda, Somalia, South Sudan, Uganda, Tanzania, Zambia, Zimbabwe, Central African Republic, Chad, Congo (Kinshasa), Congo (Brazzaville), Lesotho, Benin, Burkina Faso, Gambia, Guinea, Guinea-Bissau, Liberia, Mali, Niger, Sierra Leone, Togo, Kyrgyzstan, North Korea, Afghanistan, India, Nepal, Laos, Syria, Honduras |
|
|
HPTN 084 Qualitative Substudy Funding |
Zvavahera Chirenje, MD, FRCOG |
Kenya, Malawi, Uganda, Zimbabwe, Botswana, South Africa, Swaziland |
|
|
ACTG, AIDS Clinical Trial Research Group |
Diane Havlir, MD |
Kenya, Malawi, Uganda, Zimbabwe, Botswana, South Africa, China, India, Thailand, Brazil, Peru, Haiti |
|
|
UZ-UCSF Clinical Trials Unit |
Zvavahera Chirenje, MD, FRCOG |
Zimbabwe |
|
|
LOC-IMPAACT Leadership Group |
Theodore Ruel, MD |
Malawi, Uganda, Tanzania, Zambia, Zimbabwe, Botswana, South Africa, China, India, Thailand, Argentina, Brazil |
|
|
International Maternal Pediatric Adolescent AIDS Clinical Trial Group Master Member Agreement |
|
Malawi, Uganda, Tanzania, Zambia, Zimbabwe, Botswana, South Africa, China, India, Thailand, Argentina, Brazil, Bahamas |
|
|
Global Health diplomacy in conflict and post conflict areas |
Sebastian Kevany, MPH |
Zimbabwe, Sudan, Thailand, Iraq |
|
|
Quality Improvement Center/HEALTHQUAL |
Bruce D. Agins, MD, MPH |
Malawi, Uganda, Zimbabwe, Namibia, Nigeria, Cambodia, Viet Nam, Laos, Thailand, Haiti, Papua New Guinea |
|
|
Social Media Messaging for HIV Testing in Zimbabwe |
|
Zimbabwe |
|
|
AIDS Malignancy Consortium (AMC) |
Lawrence Kaplan, MD |
Kenya, Malawi, Uganda, Tanzania, Zimbabwe, South Africa, India, Brazil, Australia |
|
|
International Clinical Research Fellowship |
Christopher Stewart, MD |
Kenya, Uganda, Tanzania, Zimbabwe, Ghana, Liberia, Cambodia, Viet Nam |
|
|
Global Strategies for HIV Prevention |
Arthur Ammann, MD |
Zimbabwe, Congo (Kinshasa), Congo (Brazzaville), Liberia, India |
|
|
Institute for Global Orthopedics and Traumatology (IGOT) |
Richard Coughlin, MD |
Ethiopia, Kenya, Malawi, Mozambique, Rwanda, Seychelles, Uganda, Tanzania, Zambia, Zimbabwe, Cameroon, Congo (Kinshasa), Congo (Brazzaville), Egypt, Morocco, Botswana, Namibia, South Africa, Ivory Coast, Ghana, Liberia, Mali, Niger, Nigeria, Sierra Leone, Kazakhstan, Tajikistan, Uzbekistan, China, Afghanistan, Bangladesh, India, Nepal, Viet Nam, Thailand, Philippines, Costa Rica, El Salvador, Guatemala, Honduras, Mexico, Nicaragua, Brazil |
|
|
Harm reduction services for people who inject drugs |
Barrot Lambdin, PhD, MPH |
Mozambique, Tanzania, Zambia, Zimbabwe |
|
|
Diagnostics, management, & transmission of MDR TB |
John Metcalfe, MD |
Zimbabwe |
|
|
Executive Director of UCSF Global Health Sciences |
Jaime Sepulveda, MD, DSc, MPH |
Ethiopia, Kenya, Rwanda, Uganda, Tanzania, Zimbabwe, Mexico |
|
|
iBiology: Bringing the worlds best biology to you |
Ronald Vale, PhD |
Burundi, Kenya, Malawi, Mauritius, Rwanda, Seychelles, South Sudan, Uganda, Tanzania, Zambia, Zimbabwe, Cameroon, Sudan, Botswana, Lesotho, Namibia, South Africa, Swaziland, Gambia, Ghana, Liberia, Nigeria, Sierra Leone, India, Nepal, Pakistan, Singapore, Philippines, Ireland, Malta, Belize, Guyana, Antigua and Barbuda, Bahamas, Barbados, Dominica, Grenada, Jamaica, Saint Kitts and Nevis, Saint Lucia, Saint Vincent and the Grenadines, Trinidad and Tobago, Bermuda, Canada, Greenland, American Samoa, Northern Mariana Islands, Cook Islands, Fiji, Kiribati, Marshall Islands, Micronesia, Nauru, New Zealand, Niue, Palau, Papua New Guinea, Samoa, Solomon Islands, Tokelau, Tonga, Tuvalu, Vanuatu |
|
|
Strategic Information Technical Assistance Consortium |
George Rutherford, MD |
Ethiopia, Kenya, Malawi, Mozambique, Rwanda, South Sudan, Uganda, Tanzania, Zambia, Zimbabwe, Angola, Cameroon, Congo (Kinshasa), Botswana, Lesotho, Namibia, South Africa, Swaziland, Ivory Coast, Ghana, Nigeria, Kazakhstan, Kyrgyzstan, Tajikistan, Turkmenistan, Uzbekistan, China, India, Cambodia, Indonesia, Viet Nam, Laos, Thailand, Ukraine, Belize, Costa Rica, El Salvador, Guatemala, Honduras, Nicaragua, Panama, Guyana, Antigua and Barbuda, Bahamas, Barbados, Dominica, Dominican Republic, Grenada, Haiti, Jamaica, Saint Kitts and Nevis, Saint Lucia, Saint Vincent and the Grenadines, Trinidad and Tobago, Papua New Guinea |
|
|
UZ-UCSF Clinical Trials Unit |
Zvavahera Chirenje, MD, FRCOG |
Zimbabwe |
|
|
HVTN 120 Protocol Funding (PF) |
Zvavahera Chirenje, MD, FRCOG |
Zimbabwe |
|
|
UN Special Envoy for Tuberculosis: Strategic Priorities |
Eric Goosby, MD |
Ethiopia, Kenya, Mozambique, Tanzania, Zambia, Zimbabwe, Angola, Central African Republic, Congo (Kinshasa), Congo (Brazzaville), Lesotho, South Africa, Liberia, Nigeria, Sierra Leone, China, North Korea, Bangladesh, India, Pakistan, Cambodia, Indonesia, Viet Nam, Myanmar, Thailand, Philippines, Russia, Brazil, Papua New Guinea |
|
|
Population-based HIV Impact Assessments in Resource-Constrained Settings under the President's Emergency Plan for AIDS Relief (PEPFAR) |
George Rutherford, MD |
Burundi, Ethiopia, Kenya, Malawi, Mozambique, Rwanda, South Sudan, Uganda, Tanzania, Zambia, Zimbabwe, Angola, Cameroon, Congo (Kinshasa), Congo (Brazzaville), Botswana, Lesotho, Namibia, South Africa, Swaziland, Ivory Coast, Ghana, Nigeria, Kazakhstan, Kyrgyzstan, Tajikistan, Turkmenistan, Uzbekistan, China, India, Cambodia, Indonesia, Viet Nam, Laos, Thailand, Ukraine, Belize, Costa Rica, El Salvador, Guatemala, Honduras, Nicaragua, Panama, Suriname, Antigua and Barbuda, Bahamas, Barbados, Dominica, Dominican Republic, Grenada, Haiti, Jamaica, Saint Kitts and Nevis, Saint Lucia, Saint Vincent and the Grenadines, Trinidad and Tobago, Papua New Guinea |
|
|
I-TECH UCSF International AETC |
E. Michael Reyes, MD, MPH |
Ethiopia, Kenya, Malawi, Mozambique, Tanzania, Zimbabwe, Botswana, Namibia, South Africa, Ivory Coast, China, India, Guyana, Bahamas, Barbados, Haiti, Jamaica, Trinidad and Tobago |
|
|
Plugging Hair ARV Levels as Adherence Biomarkers into HIV Prevention Trials |
Monica Gandhi, MD, MPH |
Malawi, Uganda, Tanzania, Zambia, Zimbabwe, South Africa, India |
|
|
HPTN 082 - Protocol Implementation Funding |
Zvavahera Chirenje, MD, FRCOG |
Zimbabwe |
|
|
Evaluation of the Population-level Impact of PMTCT Option B+ Implemented in Zimbabwe |
|
Zimbabwe |
|
|
General Support for the UCSF Bixby Center |
J. Joseph Speidel, MD, MPH |
Kenya, Zimbabwe |
|
|
HIV Implementation Science Research Training Program |
John Metcalfe, MD |
Zimbabwe |
|
|
Accelerating progress towards Malaria Eradication: Working across Global, Regional, and National levels, and through Operational Research, to Shrink the Malaria Map |
Richard Feachem, DSc, PhD |
Zimbabwe, Swaziland |
|
|
HVTN 703/HPTN 081 Protocol Funding (PF) |
Zvavahera Chirenje, MD, FRCOG |
Kenya, Malawi, Mozambique, Tanzania, Zimbabwe, Botswana, South Africa |
|
|
HVTN 107 Protocol Funding (PF) |
Zvavahera Chirenje, MD, FRCOG |
Zimbabwe |
|
|
HPTN 084 Development Funding |
Zvavahera Chirenje, MD, FRCOG |
Zimbabwe |
|
|
Medical education and serving remote populations |
Yousef Turshani, MD |
Zimbabwe, Honduras, Nicaragua, Peru, Northern Mariana Islands |
|
|
UZ-UCSF CTU JHU IMPAACT PF: Task Order 3 |
Zvavahera Chirenje, MD, FRCOG |
Zimbabwe |
|
|
International Clinical Research Fellowships for Medical Students |
Joel Palefsky, MD |
Kenya, Uganda, Tanzania, Zimbabwe, India, Cambodia |
|
|
Decision Support Platform for Malaria Interventions: Evaluate Productivity Improvements to Indoor Residual Spraying Activity by Spatial Optimizations to Disease Surveillance and Risk Monitoring (DiSARM) Platform |
Vikram Sridharan, MS |
Zimbabwe, Botswana, Namibia, South Africa |
|
|
The Bixby Center for Global Reproductive Health - Annual Research Day Conference |
Zvavahera Chirenje, MD, FRCOG |
Zimbabwe |
|
|
Disclosure Intervention for Zimbabwean Parents: Y 4 RPPR processed as renewal for P subaccount transition |
|
Zimbabwe |
|
|
HPTN 081 Protocol Funding - Development Costs |
Zvavahera Chirenje, MD, FRCOG |
Zimbabwe |
|
|
IMPAACT Yr 08 P1077 CTU MOU #2 - Parirenyatwa |
Zvavahera Chirenje, MD, FRCOG |
Zimbabwe |
|
|
IMPAACT Yr 08 P1077 CTU MOU #2 - Seke North |
Zvavahera Chirenje, MD, FRCOG |
Zimbabwe |
|
|
IMPAACT Yr 08 P1077 CTU MOU #2 - St. Mary's |
Zvavahera Chirenje, MD, FRCOG |
Zimbabwe |
|
|
UCSF-GIVI Center for AIDS Research (CFAR) |
Paul Volberding, MD |
Kenya, Uganda, Tanzania, Zimbabwe, South Africa, Peru |
|
|
UZ-UCSF CTU Spilhaus Clinical Research Site HPTN 076 2nd Protocol Funding |
Zvavahera Chirenje, MD, FRCOG |
Zimbabwe |
|
|
University of California Global Health Institute Program for Fellows and Scholars |
Craig Cohen, MD, MPH |
Ethiopia, Kenya, Mozambique, Uganda, Tanzania, Zimbabwe, China, Bangladesh, India, Ukraine, Guatemala, Mexico, Panama, Brazil, Chile, Peru |
|
|
Mobile Technology for Malaria Elimination: |
Emma Zorensky, MS |
Zimbabwe, Botswana, Namibia, Swaziland |
|
|
Cost-effectiveness Analysis of “Safer” Conception Strategies for HIV-Discordant Couples in Zimbabwe |
Carolyn Smith Hughes, MS |
Zimbabwe |
|
|
Disclosure Intervention for Zimbabwean Parents |
|
Zimbabwe |
|
|
2.1 Project Title ACTG: AIDS Clinical Trials Group |
Francesca Aweeka, PharmD |
Kenya, Mozambique, Uganda, Zimbabwe, Botswana, South Africa, India, Thailand, Brazil, Peru |
|
|
LOC-IMPAACT Leadership Group |
Francesca Aweeka, PharmD |
Malawi, Uganda, Tanzania, Zambia, Zimbabwe, Botswana, South Africa, China, India, Thailand, Brazil |
|
|
Evaluating Shock Index Trajectories for Improving Management of Obstetric Hemorrhage |
Alison El Ayadi, ScD, MPH |
Zambia, Zimbabwe, Egypt, Nigeria |
|
|
Center for AIDS Prevention Studies |
Stephen Morin, PhD |
Kenya, Mozambique, Uganda, Tanzania, Zimbabwe, Botswana, South Africa, China, India, Nepal, Thailand, Philippines, Brazil |
|
|
UZ-UCSF CTU Parirenyatwa Clinical Research Site HPTN 052 2nd Protocol Funding |
Zvavahera Chirenje, MD, FRCOG |
Zimbabwe |
|
|
UAB-UCSF Creative and Novel Ideas in HIV Research |
Paul Volberding, MD |
Kenya, Uganda, Tanzania, Zimbabwe, South Africa, Ivory Coast, India, Cambodia, Viet Nam, Thailand, Brazil, Peru |
|
|
Immunologic Consequences of Highly Effective Antimalarial Chemoprevention |
|
Uganda, Zimbabwe |
|
|
Improving Early Identification of Drug Resistant Tuberculosis in HIV Prevalent Settings |
John Metcalfe, MD |
Zimbabwe |
|
|
Office of the UN Special Envoy for Tuberculosis |
Eric Goosby, MD |
Burundi, Comoros, Djibouti, Eritrea, Ethiopia, Kenya, Madagascar, Malawi, Mauritius, Mozambique, Rwanda, Seychelles, Somalia, South Sudan, Uganda, Tanzania, Zambia, Zimbabwe, Angola, Cameroon, Central African Republic, Chad, Congo (Kinshasa), Congo (Brazzaville), Equatorial Guinea, Gabon, Sao Tome and Principe, Algeria, Egypt, Libya, Morocco, Sudan, Tunisia, Western Sahara, Botswana, Lesotho, Namibia, South Africa, Swaziland, Benin, Burkina Faso, Cape Verde, Ivory Coast, Gambia, Ghana, Guinea, Guinea-Bissau, Liberia, Mali, Mauritania, Niger, Nigeria, Senegal, Sierra Leone, Togo, Central Asia, Kazakhstan, Kyrgyzstan, Tajikistan, Turkmenistan, Uzbekistan, China, Hong Kong S.A.R., China, North Korea, South Korea, Macao S.A.R., China, Mongolia, Afghanistan, Bangladesh, Bhutan, India, Iran, Maldives, Nepal, Sri Lanka, Brunei, Cambodia, Indonesia, Viet Nam, Laos, Malaysia, Myanmar, Singapore, Thailand, Timor-Leste, Philippines, Armenia, Azerbaijan, Bahrain, Cyprus, Georgia, Iraq, Israel, Jordan, Kuwait, Lebanon, Oman, Palestinian Territory, Qatar, Saudi Arabia, Syria, Turkey, United Arab Emirates, Yemen, Albania, Andorra, Austria, Belarus, Belgium, Bosnia and Herzegovina, Bulgaria, Croatia, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Jersey, Kosovo, Latvia, Liechtenstein, Lithuania, Luxembourg, Macedonia, Malta, Moldova, Monaco, Montenegro, Netherlands, Norway, Poland, Portugal, Romania, Russia, San Marino, Serbia, Slovakia, Slovenia, Spain, Sweden, Switzerland, Ukraine, United Kingdom, Belize, Costa Rica, El Salvador, Guatemala, Honduras, Mexico, Nicaragua, Panama, Bolivia, Brazil, Chile, Colombia, Ecuador, French Guiana, Guyana, Paraguay, Peru, Suriname, Uruguay, Venezuela, Caribbean, Anguilla, Turks and Caicos Islands, Antigua and Barbuda, Aruba, Bahamas, Barbados, Cayman Islands, Cuba, Dominica, Dominican Republic, Grenada, Guadeloupe, Haiti, Jamaica, Martinique, Puerto Rico, Saint Kitts and Nevis, Saint Lucia, Saint Vincent and the Grenadines, Trinidad and Tobago, Bermuda, Canada, Greenland, U.S. Virgin Islands, American Samoa, Northern Mariana Islands, Australia, Cook Islands, Guam, French Polynesia, Fiji, Kiribati, Marshall Islands, Micronesia, Nauru, New Zealand, Niue, Palau, Papua New Guinea, Samoa, Solomon Islands, Tokelau, Tonga, Tuvalu, Vanuatu |
|
|
Systematic reviews to support the Antiretroviral Therapy (ART) Consolidated Guidelines - 2014/HTM/HIV/007 |
George Rutherford, MD |
Eritrea, Ethiopia, Kenya, Madagascar, Malawi, Mauritius, Mozambique, Rwanda, Somalia, South Sudan, Uganda, Tanzania, Zambia, Zimbabwe, Angola, Cameroon, Central African Republic, Chad, Congo (Kinshasa), Congo (Brazzaville), Equatorial Guinea, Gabon, Sao Tome and Principe, Algeria, Egypt, Libya, Morocco, Sudan, Tunisia, Botswana, Lesotho, Namibia, South Africa, Swaziland, Western Africa, Benin, Burkina Faso, Ivory Coast, Gambia, Ghana, Liberia, Mali, Mauritania, Niger, Nigeria, Sierra Leone, Kazakhstan, Kyrgyzstan, Tajikistan, Turkmenistan, Uzbekistan, China, South Korea, Afghanistan, Bangladesh, Bhutan, India, Iran, Maldives, Nepal, Pakistan, Sri Lanka, Cambodia, Indonesia, Viet Nam, Laos, Malaysia, Myanmar, Singapore, Thailand, Timor-Leste, Philippines, Armenia, Georgia, Iraq, Israel, Jordan, Kuwait, Saudi Arabia, Syria, Turkey, United Arab Emirates, Yemen, Bosnia and Herzegovina, Bulgaria, Croatia, Macedonia, Moldova, Slovenia, Belize, Costa Rica, El Salvador, Guatemala, Honduras, Mexico, Nicaragua, Panama, Argentina, Bolivia, Brazil, Chile, Colombia, Ecuador, French Guiana, Paraguay, Peru, Uruguay, Venezuela, Turks and Caicos Islands, Antigua and Barbuda, Aruba, Bahamas, Barbados, Cayman Islands, Dominica, Dominican Republic, Haiti, Jamaica, Saint Kitts and Nevis, Saint Lucia, Saint Vincent and the Grenadines, Trinidad and Tobago, American Samoa, Northern Mariana Islands, Guam, Fiji, Marshall Islands, Micronesia, Palau, Papua New Guinea, Samoa, Solomon Islands, Vanuatu |
|
|
Oral HIV/AIDS Research Alliance |
Caroline Shiboski, DDS, MPH, PhD |
Uganda, Zimbabwe, Botswana, South Africa, India, Argentina |
|
|
UZ-UCSF CTU Spilhaus Clinical Research Site HPTN 076 2nd Protocol Funding |
Zvavahera Chirenje, MD, FRCOG |
Zimbabwe |
|
|
The Contribution of Unsafe Blood Transfusion to HIV Transmission in Africa: A Literature Review |
Malika Morar, MS |
Burundi, Comoros, Djibouti, Eritrea, Ethiopia, Kenya, Madagascar, Malawi, Mauritius, Mozambique, Rwanda, Seychelles, Somalia, South Sudan, Uganda, Tanzania, Zambia, Zimbabwe, Angola, Cameroon, Central African Republic, Chad, Congo (Kinshasa), Congo (Brazzaville), Equatorial Guinea, Gabon, Sao Tome and Principe, Algeria, Egypt, Libya, Morocco, Sudan, Tunisia, Western Sahara, Botswana, Lesotho, Namibia, South Africa, Swaziland, Benin, Burkina Faso, Cape Verde, Ivory Coast, Gambia, Ghana, Guinea, Guinea-Bissau, Liberia, Mali, Mauritania, Niger, Nigeria, Senegal, Sierra Leone, Togo |
|
|
AIDS Malignancies Consortium |
Lawrence Kaplan, MD |
Kenya, Uganda, Zimbabwe, South Africa, India, Brazil, Australia |
|
|
External Evaluation of Elizabeth Glaser Pediatric AIDS Foundation's Prevention of Mother to Child Transmission of HIV Programme in Zimbabwe |
|
Zimbabwe |
|
|
St Marys - International Maternal Pediatric Adolescent AIDS Clinical Trials Group UZ |
Zvavahera Chirenje, MD, FRCOG |
Zimbabwe |
|
|
Seke North - International Maternal Pediatric Adolescent AIDS Clinical Trials Group UZ |
Zvavahera Chirenje, MD, FRCOG |
Zimbabwe |
|
|
Parirenyatwa - International Maternal Pediatric Adolescent AIDS Clinical Trials Group UZ UCSF CTU |
Zvavahera Chirenje, MD, FRCOG |
Zimbabwe |
|
|
Women, Children, and HIV Website |
Susan Coffey, MD |
Kenya, Malawi, Mauritius, Mozambique, Rwanda, Seychelles, Somalia, Uganda, Tanzania, Zambia, Zimbabwe, Angola, Cameroon, Central African Republic, Chad, Botswana, Lesotho, Namibia, South Africa, Swaziland, Gambia, Ghana, Liberia, Nigeria, India, Pakistan, Sri Lanka, Singapore, Philippines, United Kingdom, Anguilla, Antigua and Barbuda, Bahamas, Barbados, Cayman Islands, Dominica, Grenada, Jamaica, Saint Kitts and Nevis, Saint Lucia, Trinidad and Tobago, U.S. Virgin Islands, Northern Mariana Islands, Australia, Marshall Islands, Palau, Papua New Guinea, Samoa, Solomon Islands, Tokelau, Tonga, Tuvalu, Vanuatu |
|
|
M tuberculosis Cells from Patients with Tuberculosis |
Midori Kato-Maeda, MD |
Tanzania, Zimbabwe, Panama |
|
|
Interventions for Improving Retention in Antiretroviral Therapy (ART) Programs (PO 200988865) |
George Rutherford, MD |
Burundi, Comoros, Djibouti, Eritrea, Ethiopia, Kenya, Madagascar, Malawi, Mauritius, Mozambique, Rwanda, Seychelles, Somalia, South Sudan, Uganda, Tanzania, Zambia, Zimbabwe, Angola, Cameroon, Central African Republic, Chad, Congo (Kinshasa), Congo (Brazzaville), Equatorial Guinea, Gabon, Sao Tome and Principe, Algeria, Egypt, Libya, Morocco, Sudan, Tunisia, Western Sahara, Botswana, Lesotho, Namibia, South Africa, Swaziland, Benin, Burkina Faso, Cape Verde, Ivory Coast, Gambia, Ghana, Guinea, Guinea-Bissau, Liberia, Mali, Mauritania, Niger, Nigeria, Senegal, Sierra Leone, Togo, Kazakhstan, Kyrgyzstan, Tajikistan, Turkmenistan, Uzbekistan, Mongolia, Afghanistan, Bangladesh, Bhutan, India, Iran, Maldives, Nepal, Pakistan, Sri Lanka, Brunei, Cambodia, Indonesia, Viet Nam, Laos, Malaysia, Myanmar, Thailand, Timor-Leste, Philippines, Armenia, Azerbaijan, Georgia, Iraq, Jordan, Lebanon, Syria, Turkey, Yemen, Albania, Bosnia and Herzegovina, Bulgaria, Croatia, Montenegro, Slovakia, Slovenia, Belize, Costa Rica, El Salvador, Guatemala, Honduras, Mexico, Nicaragua, Panama, Argentina, Bolivia, Brazil, Ecuador, Peru, Uruguay, Venezuela, Haiti, Jamaica |
|
|
Doris Duke Clinical Research Fellowship Renewal |
Joel Palefsky, MD |
Kenya, Uganda, Tanzania, Zimbabwe, India, Cambodia |
|
|
Non-Pneumatic Anti-Shock Garment for Obstetric Hemorrhage |
Suellen Miller, PhD, CNM, MHA |
Zambia, Zimbabwe |
|
|
Microbicide Pregnancy Registry--Microbicide Trials Network |
Juan Vargas, MD |
Malawi, Uganda, Zambia, Zimbabwe, South Africa, India, Thailand, Peru, Puerto Rico |
|
|
University of Zimbabwe-UCSF Clinical Trials Unit |
Zvavahera Chirenje, MD, FRCOG |
Zimbabwe |
|
|
Non-Pneumatic Anti-Shock Garment for Obstetrical Hemorrhage |
Suellen Miller, PhD, CNM, MHA |
Zambia, Zimbabwe |
|
|
CAPS/Fogarty Visiting Scientists and In-Country Research Training Activities |
George Rutherford, MD |
Ethiopia, Kenya, Rwanda, Uganda, Tanzania, Zambia, Zimbabwe, Egypt, Sudan, South Africa, Burkina Faso, Ghana, Nigeria, Senegal, Kazakhstan, China, Japan, India, Iran, Nepal, Cambodia, Indonesia, Viet Nam, Thailand, Philippines, Georgia, Jordan, Croatia, Czech Republic, Russia, Costa Rica, Guatemala, Mexico, Argentina, Brazil, Chile, Ecuador, Peru, Venezuela, Dominican Republic, Puerto Rico, Trinidad and Tobago, Canada |
|
|
International Training and Education Center for Health (I-TECH) |
E. Michael Reyes, MD, MPH |
Ethiopia, Kenya, Malawi, Mozambique, Tanzania, Zimbabwe, Botswana, Namibia, South Africa, Ivory Coast, China, India, Viet Nam, Guyana, Bahamas, Barbados, Haiti, Jamaica, Trinidad and Tobago |
|
|
WHO Adolescent HTC Review Update (PO# 200660799) |
George Rutherford, MD |
Burundi, Comoros, Djibouti, Eritrea, Ethiopia, Kenya, Madagascar, Malawi, Mauritius, Mozambique, Rwanda, Seychelles, Somalia, South Sudan, Uganda, Tanzania, Zambia, Zimbabwe, Angola, Cameroon, Central African Republic, Chad, Congo (Kinshasa), Congo (Brazzaville), Equatorial Guinea, Gabon, Sao Tome and Principe, Algeria, Egypt, Libya, Morocco, Sudan, Tunisia, Western Sahara, Botswana, Lesotho, Namibia, South Africa, Swaziland, Western Africa, Benin, Burkina Faso, Cape Verde, Ivory Coast, Gambia, Ghana, Guinea, Guinea-Bissau, Liberia, Mali, Mauritania, Niger, Nigeria, Senegal, Sierra Leone, Togo, Kazakhstan, Kyrgyzstan, Tajikistan, Turkmenistan, Uzbekistan, China, Hong Kong S.A.R., China, North Korea, Japan, Macao S.A.R., China, Mongolia, Afghanistan, Bangladesh, Bhutan, India, Iran, Maldives, Nepal, Pakistan, Sri Lanka, Brunei, Indonesia, Viet Nam, Laos, Malaysia, Myanmar, Singapore, Thailand, Timor-Leste, Philippines, Armenia, Azerbaijan, Bahrain, Cyprus, Georgia, Iraq, Israel, Jordan, Kuwait, Lebanon, Oman, Palestinian Territory, Qatar, Saudi Arabia, Syria, Turkey, United Arab Emirates, Yemen, Albania, Andorra, Austria, Belarus, Belgium, Bosnia and Herzegovina, Bulgaria, Croatia, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Jersey, Kosovo, Latvia, Liechtenstein, Lithuania, Luxembourg, Macedonia, Malta, Moldova, Monaco, Montenegro, Netherlands, Norway, Poland, Portugal, Romania, Russia, San Marino, Serbia, Slovakia, Slovenia, Spain, Sweden, Switzerland, Ukraine, United Kingdom, Belize, Costa Rica, El Salvador, Guatemala, Honduras, Mexico, Nicaragua, Panama, Argentina, Bolivia, Brazil, Chile, Colombia, Ecuador, French Guiana, Guyana, Paraguay, Peru, Suriname, Uruguay, Venezuela, Anguilla, Turks and Caicos Islands, Antigua and Barbuda, Aruba, Bahamas, Barbados, Cayman Islands, Cuba, Dominica, Dominican Republic, Grenada, Guadeloupe, Haiti, Jamaica, Martinique, Puerto Rico, Saint Kitts and Nevis, Saint Lucia, Saint Vincent and the Grenadines, Trinidad and Tobago, Bermuda, Canada, Greenland, U.S. Virgin Islands, American Samoa, Northern Mariana Islands, Australia, Cook Islands, Guam, French Polynesia, Fiji, Kiribati, Marshall Islands, Micronesia, Nauru, New Zealand, Niue, Palau, Papua New Guinea, Samoa, Solomon Islands, Tokelau, Tonga, Tuvalu, Vanuatu |
|
|
Advancing Academic Understanding of the Private Sector, and Strengthening the Social Franchising Community of Practice |
Dominic Montagu, DrPH |
Burundi, Ethiopia, Kenya, Madagascar, Malawi, Mozambique, Rwanda, Somalia, Uganda, Tanzania, Zambia, Zimbabwe, Cameroon, Congo (Kinshasa), Sudan, South Africa, Benin, Mali, Senegal, Sierra Leone, Togo, China, Bangladesh, India, Nepal, Pakistan, Cambodia, Indonesia, Viet Nam, Laos, Myanmar, Philippines, Yemen, El Salvador, Guatemala, Nicaragua, Peru, Papua New Guinea |
|
|
University of California Global Health Institute Women's Health and Empowerment Center of Expertise Post-Doctoral Fellowship Program |
Craig Cohen, MD, MPH |
Burundi, Comoros, Djibouti, Eritrea, Ethiopia, Kenya, Madagascar, Malawi, Mauritius, Mozambique, Rwanda, Seychelles, Somalia, South Sudan, Uganda, Tanzania, Zambia, Zimbabwe, Angola, Cameroon, Central African Republic, Chad, Congo (Kinshasa), Congo (Brazzaville), Equatorial Guinea, Gabon, Sao Tome and Principe, Algeria, Egypt, Libya, Morocco, Sudan, Tunisia, Botswana, Lesotho, Namibia, South Africa, Swaziland, Benin, Burkina Faso, Cape Verde, Ivory Coast, Gambia, Ghana, Guinea, Guinea-Bissau, Liberia, Mali, Mauritania, Niger, Nigeria, Senegal, Sierra Leone, Togo, Kazakhstan, Kyrgyzstan, Tajikistan, Turkmenistan, Uzbekistan, China, North Korea, South Korea, Mongolia, Afghanistan, Bangladesh, Bhutan, India, Iran, Maldives, Nepal, Pakistan, Sri Lanka, Cambodia, Indonesia, Viet Nam, Laos, Malaysia, Myanmar, Thailand, Timor-Leste, Philippines, Armenia, Azerbaijan, Georgia, Iraq, Jordan, Lebanon, Palestinian Territory, Syria, Turkey, Yemen, Albania, Belarus, Bosnia and Herzegovina, Bulgaria, Kosovo, Latvia, Lithuania, Macedonia, Moldova, Montenegro, Romania, Russia, Serbia, Ukraine, Belize, Costa Rica, El Salvador, Guatemala, Honduras, Mexico, Nicaragua, Panama, Argentina, Bolivia, Brazil, Chile, Colombia, Ecuador, French Guiana, Guyana, Paraguay, Peru, Suriname, Uruguay, Venezuela, Antigua and Barbuda, Cuba, Dominica, Grenada, Haiti, Jamaica, Saint Lucia, Saint Vincent and the Grenadines, American Samoa, Fiji, Kiribati, Marshall Islands, Micronesia, Palau, Papua New Guinea, Samoa, Solomon Islands, Tonga, Tuvalu, Vanuatu |
|
|
UCSF-Gladstone Center for AIDS Research (CFAR) |
Paul Volberding, MD |
Kenya, Uganda, Tanzania, Zimbabwe, South Africa, Peru |
|
|
Community-based VCT: Zimbabwe |
Stephen Morin, PhD |
Tanzania, Zimbabwe, South Africa, Thailand |
|
|
Global Health Sciences Clinical Scholars Program Immersion Experience |
Christopher Stewart, MD |
Burundi, Comoros, Djibouti, Eritrea, Ethiopia, Kenya, Madagascar, Malawi, Mauritius, Mozambique, Rwanda, Seychelles, Somalia, South Sudan, Uganda, Tanzania, Zambia, Zimbabwe, Angola, Cameroon, Central African Republic, Chad, Congo (Kinshasa), Congo (Brazzaville), Gabon, Sao Tome and Principe, Algeria, Egypt, Libya, Morocco, Sudan, Tunisia, Botswana, Lesotho, Namibia, South Africa, Swaziland, Benin, Burkina Faso, Cape Verde, Ivory Coast, Gambia, Ghana, Guinea, Guinea-Bissau, Liberia, Mali, Mauritania, Niger, Nigeria, Senegal, Sierra Leone, Togo, Kazakhstan, Kyrgyzstan, Tajikistan, Turkmenistan, Uzbekistan, China, North Korea, Mongolia, Afghanistan, Bangladesh, Bhutan, India, Iran, Maldives, Nepal, Pakistan, Sri Lanka, Cambodia, Indonesia, Viet Nam, Laos, Malaysia, Myanmar, Thailand, Timor-Leste, Philippines, Armenia, Azerbaijan, Georgia, Iraq, Israel, Jordan, Lebanon, Palestinian Territory, Syria, Turkey, Yemen, Albania, Belarus, Bosnia and Herzegovina, Bulgaria, Croatia, Kosovo, Latvia, Lithuania, Macedonia, Moldova, Montenegro, Romania, Russia, Serbia, Ukraine, Belize, Costa Rica, El Salvador, Guatemala, Honduras, Mexico, Nicaragua, Panama, Argentina, Bolivia, Brazil, Chile, Colombia, Ecuador, Guyana, Paraguay, Peru, Suriname, Uruguay, Venezuela, Antigua and Barbuda, Cuba, Dominica, Dominican Republic, Grenada, Haiti, Jamaica, Saint Lucia, Saint Vincent and the Grenadines, American Samoa, Fiji, Kiribati, Marshall Islands, Micronesia, Palau, Papua New Guinea, Samoa, Solomon Islands, Tonga, Tuvalu, Vanuatu |
|
|
Non-Pneumatic Anti-Shock Garment for Obstetrical Hemorrhage |
Suellen Miller, PhD, CNM, MHA |
Zambia, Zimbabwe |
|
|
Microbicide Pregnancy Registry-Microbicide Trials Network |
Juan Vargas, MD |
Malawi, Uganda, Zambia, Zimbabwe, South Africa, India, Peru |
|
|
International Maternal Adolescent AIDS Clinical Trials Group - Master Subcontract |
Diane Wara, MD |
Uganda, Tanzania, Zambia, Zimbabwe, Botswana, South Africa, India, Thailand |
|
|
T001: Adult AIDS Clinical Trials Group (AACTG): Pharmacology Laboratory |
Francesca Aweeka, PharmD |
Kenya, Malawi, Tanzania, Zambia, Zimbabwe, Botswana, South Africa, India, Thailand, Brazil, Peru, Haiti, Puerto Rico, United States |
|
|
Role of the Informal Sector in Mixed Health Services Project |
Dominic Montagu, DrPH |
Burundi, Ethiopia, Kenya, Madagascar, Malawi, Mozambique, Rwanda, Somalia, Uganda, Tanzania, Zambia, Zimbabwe, Cameroon, Congo (Kinshasa), Sudan, South Africa, Benin, Ghana, Mali, Nigeria, Senegal, Sierra Leone, Togo, China, Bangladesh, India, Nepal, Pakistan, Cambodia, Indonesia, Viet Nam, Laos, Myanmar, Philippines, Yemen, El Salvador, Guatemala, Nicaragua, Peru, Papua New Guinea |
|
|
UCSF-GIVI Center for AIDS Research . |
Paul Volberding, MD |
Kenya, Uganda, Tanzania, Zimbabwe, South Africa, Peru |
|
|
Clinical Care Response Team Introduction of Antiretroviral Therapy in Elizabeth Glaser Pediatric AIDS Foundation Sites |
Diane Havlir, MD |
Kenya, Uganda, Tanzania, Zimbabwe, South Africa, Ivory Coast |
|
|
Improving Data on Private Healthcare Use and Provision |
Dominic Montagu, DrPH |
Burundi, Ethiopia, Kenya, Madagascar, Malawi, Mozambique, Rwanda, Somalia, Uganda, Tanzania, Zambia, Zimbabwe, Cameroon, Congo (Kinshasa), Sudan, South Africa, Benin, Ghana, Mali, Nigeria, Senegal, Sierra Leone, Togo, China, Bangladesh, India, Nepal, Pakistan, Cambodia, Indonesia, Viet Nam, Laos, Myanmar, Philippines, Yemen, El Salvador, Guatemala, Nicaragua, Peru, Papua New Guinea |
|
|
AIDS Policy Research Center |
Stephen Morin, PhD |
Tanzania, Zimbabwe, South Africa, Kazakhstan, China, Japan, India, Cambodia, Viet Nam, Thailand, Philippines, Croatia, South America, Argentina, Brazil, Peru, Antigua and Barbuda, Barbados, Saint Kitts and Nevis, Saint Vincent and the Grenadines |
|
|
Center for AIDS Prevention Studies |
Stephen Morin, PhD |
Kenya, Uganda, Tanzania, Zambia, Zimbabwe, South Africa, China, India, Iran, Nepal, Cambodia, Viet Nam, Myanmar, Thailand, Argentina, Peru |
|
|
UZ-UCSF Collaborative Research Program |
Suellen Miller, PhD, CNM, MHA |
Zimbabwe |
|
|
UZ-UCSF Clinical Trials Unit |
Zvavahera Chirenje, MD, FRCOG |
Zimbabwe |
|
|
Congenital Syphilis Elimination Cost-Effectiveness Analysis |
James Kahn, MD, MPH |
Burundi, Comoros, Djibouti, Madagascar, Malawi, Mauritius, Mozambique, Rwanda, Tanzania, Zambia, Zimbabwe, Cameroon, Central African Republic, Chad, Congo (Brazzaville), Gabon, Sao Tome and Principe, Sudan, Tunisia, Botswana, Namibia, South Africa, Swaziland, Benin, Burkina Faso, Ivory Coast, Ghana, Guinea, Mali, Nigeria, Sierra Leone, Togo, Kazakhstan, Kyrgyzstan, Uzbekistan, China, Mongolia, Afghanistan, Bangladesh, India, Maldives, Nepal, Sri Lanka, Cambodia, Indonesia, Viet Nam, Laos, Malaysia, Myanmar, Thailand, Philippines, Jordan, Oman, Saudi Arabia, Belarus, Czech Republic, Estonia, Germany, Hungary, Lithuania, Macedonia, Moldova, Romania, United Kingdom, Costa Rica, El Salvador, Guatemala, Honduras, Mexico, Panama, Argentina, Bolivia, Brazil, Chile, Colombia, Ecuador, Guyana, Paraguay, Peru, Uruguay, Antigua and Barbuda, Cuba, Dominica, Dominican Republic, Grenada, Trinidad and Tobago, Fiji, Kiribati, Papua New Guinea |
|
|
Fogarty International AIDS Training |
Paul Volberding, MD |
Kenya, Uganda, Zimbabwe, Ivory Coast, India, Brazil, Peru |
|
|
Microbicide Pregnancy Registry--Microbicide Trials Network |
Juan Vargas, MD |
Malawi, Uganda, Zambia, Zimbabwe, South Africa, India, Thailand, Peru |
|
|
Doris Duke Charitable Foundation International Clinical Research Fellowship Program |
Joel Palefsky, MD |
Kenya, Uganda, Tanzania, Zimbabwe, Ghana, Cambodia, Thailand, Nicaragua |
|
|
Safe Abortion Services and Advocacy in Zimbabwe and Tanzania |
J. Joseph Speidel, MD, MPH |
Tanzania, Zimbabwe |
|
|
Economic Opportunity for Zimbabwean Adolescent Orphans |
Philip Darney, MD, MS |
Zimbabwe |
|
|
International CAPS/Fogarty Visiting Scientists |
George Rutherford, MD |
Uganda, Zimbabwe, Ivory Coast, India, Cambodia, Viet Nam, Thailand, Brazil, Peru |
|
|
Duet and Menstrual Protection |
Ariane Van der Straten, PhD, MPH |
Zimbabwe |
|
|
Providers' Perceptions of the Diaphragm in Southern Africa and the United States |
Cynthia Harper, PhD |
Zimbabwe, South Africa |
|
|
Community-Based HIV VCT: Zimbabwe |
Stephen Morin, PhD |
Tanzania, Zimbabwe, Southern Africa, Thailand, United States |
|
|
CFAR International Scientist Training Awards / International AIDS Training Program |
Paul Volberding, MD |
Zimbabwe, Ivory Coast, India, Cambodia, Viet Nam, Thailand, Brazil, Peru |
|
|
Hormonal Contraception and the Risk of HIV Acquisition |
|
Zimbabwe |
|
|
A Randomized Placebo-Controlled Trial to Evaluate the Effectiveness of Antiretroviral Therapy to Reduce Transmission of HIV-1 in Serodiscordant Couples |
|
Zimbabwe |
|
|
A Phase I Safety Trial of the Diaphragm in Zimbabwe |
|
Zimbabwe |
|
|
Preventing HIV by Protecting the Cervix |
|
Zimbabwe, South Africa |
|
|
The Zimbabwe-San Francisco HIV Prevention Trials Unit |
|
Zimbabwe |
|
|
Coming Together to Overcome HIV/AIDS in Zimbabwe and Zambia |
|
Zambia, Zimbabwe |
|
|
Zimbabwe San Francisco HPTN Fogarty Training / International AIDS Training Program |
|
Zimbabwe |
|
|
HIV-Related Oral Diseases Among Women in Harare |
John Greenspan, BDS, PhD |
Zimbabwe |
|
|
Building Community Partnerships: Case Studies at Three HPTN Sites |
Stephen Morin, PhD |
Zimbabwe, Thailand, Peru |
|
|
International AIDS Education and Training Center |
E. Michael Reyes, MD, MPH |
Ethiopia, Kenya, Madagascar, Malawi, Mozambique, Rwanda, Somalia, Uganda, Tanzania, Zambia, Zimbabwe, Angola, Cameroon, Gabon, Egypt, Morocco, Sudan, Tunisia, Botswana, Namibia, South Africa, Swaziland, Benin, Burkina Faso, Ivory Coast, Gambia, Ghana, Guinea-Bissau, Mali, Niger, Nigeria, Senegal, Togo, Kyrgyzstan, China, Bangladesh, India, Iran, Nepal, Pakistan, Sri Lanka, Cambodia, Indonesia, Viet Nam, Laos, Myanmar, Singapore, Thailand, Timor-Leste, Philippines, Georgia, Iraq, Lebanon, Yemen, Czech Republic, Estonia, Greece, Belize, Costa Rica, El Salvador, Guatemala, Honduras, Argentina, Bolivia, Brazil, Chile, Colombia, Ecuador, Guyana, Paraguay, Peru, Venezuela, Antigua and Barbuda, Bahamas, Barbados, Dominica, Dominican Republic, Grenada, Haiti, Jamaica, Puerto Rico, Trinidad and Tobago, Australia |
|
|
Improving Uses of New and Existing Technologies to Reduce Non-viral STIs in Developing Countries |
|
Zimbabwe |
|
|
HIV Risk Reduction Through HSV-2 Prevention with N-9 |
|
Zimbabwe |
|
|